Well Friends, the Prader Willi circle in relation to Acadia's...

Well Friends,
the Prader Willi circle in relation to Acadia's interests is fading. maybe it's coincidental or maybe not, but Levo (which is under Acadia's control on the sly) put forward its patent late last year and works closely with Massachusetts General Hospital. exactly the hospital where our Liza Squires was trained in many years of pediatric activity. Liza joined Neuren in July 2022 with the clear goal stated by Neuren to work on the PW project.

https://worldwide.espacenet.com/patent/search/family/083932466/publication/WO2022236296A1?q=pn%3DWO2022236296

Neuren (NEU) – ASX Announcement 8 July 2022
Neuren appoints Chief Medical Officer in United States
Melbourne, Australia: Neuren Pharmaceuticals (ASX: NEU) today announced the appointment
of Liza A. Squires M.D. to the new position of Chief Medical Officer, based in the United States.
Dr Squires is a board certified physician in General Pediatrics and Neurology with Special
Competence in Child Neurology. Over the past 20 years, she has held positions of increasing
responsibilities in both early and late-stage development at Johnson and Johnson, Shire
Pharmaceuticals, Lumos Pharma, Aevi Genomic Medicine and Origin Biosciences. She has led
and contributed to multiple New Drug Applications resulting in global regulatory approvals and
has extensive experience in orphan drug development.
Dr Squires trained in general pediatrics at Yale University and did her residency in Child
Neurology at Massachusetts General Hospital.
Neuren CEO Jon Pilcher commented: “I am very pleased to welcome Liza at such an exciting
time for Neuren. Her ideal skills and experience in pediatric neurology and orphan drug
development will make a big difference to the team as we advance our ambitious plans for
NNZ-2591 in multiple indications.